Search

Displaying results 9431 - 9440 of 10000 in total
  1. Drug

    Esuberaprost

    go.drugbank.com/drugs/DB18464
    Investigational

    Esuberaprost (GP-1681), a drug intended for participants with pulmonary arterial hypertension, was under investigation in clinical trial NCT03657095 to evaluate its efficacy and safety.

  2. Drug

    Spevatamig

    go.drugbank.com/drugs/DB18471
    Investigational

    PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47)

  3. Drug

    PT217

    go.drugbank.com/drugs/DB18472
    Investigational

    PT217 is a bispecific Antibody against DLL3 and CD47

  4. Drug

    ASP-2138

    go.drugbank.com/drugs/DB18473
    Investigational

    ASP-2138 is a bispecific antibody directed against CLDN18.2 and T cell receptor complex CD3

  5. Drug

    VBI-1901

    go.drugbank.com/drugs/DB18476
    Investigational

    VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles

  6. Drug

    KT-253

    go.drugbank.com/drugs/DB18487
    Investigational

    KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).

  7. Drug

    DMP-777

    go.drugbank.com/drugs/DB18488
    Experimental

    DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.

  8. Drug

    Elenestinib

    go.drugbank.com/drugs/DB18489
    Investigational

    Elenestinib is a selective KIT inhibitor.

  9. Drug

    LTI-03

    go.drugbank.com/drugs/DB18491
    Investigational

    LTI-03 is a caveolin-1 Scaffolding Domain 7-Mer

  10. Drug

    STP-707

    go.drugbank.com/drugs/DB18499
    Investigational

    STP-707 is a small interfering RNA (siRNA) targeting TGF-Beta1 and COX-2 mRNA.